GAA and glycogen storage disease II: Mutations in the GAA gene cause glycogen-storage disease type II (GSDII; Pompe disease, acid maltase deficiency, MIM 232300), a neuromuscular LSD characterized by the deficit of α-glucosidase activity, resulting in the lack of glycogen degradation and its progressive accumulation within the lysosomes [24].